CIK 0001799448 · Non-accelerated filer<br>Smaller reporting company
Aligos Therapeutics, Inc.
Sign in to watch- Ticker
- ALGS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (800) 466-6059
- Business address
- ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-20 | Vivo Capital VIII, LLC 10% owner | Conversion | +260,380 | 260,380 | ||
| 2020-10-20 | Vivo Capital VIII, LLC 10% owner | Conversion | +72,320 | 332,700 | ||
| 2020-10-20 | Vivo Capital VIII, LLC 10% owner | Conversion | +30,939 | 363,639 | ||
| 2020-10-20 | Vivo Capital VIII, LLC 10% owner | Purchase | +483,267 | $15.00 | $7.2M | 3,116,658 |
| 2020-10-20 | Vivo Capital VIII, LLC 10% owner | Purchase | +66,733 | $15.00 | $1.0M | 430,372 |
| 2020-10-20 | Vivo Capital VIII, LLC 10% owner | Conversion · Series A Preferred Stock | −1,885,611 | 0 | ||
| 2020-10-20 | Vivo Capital VIII, LLC 10% owner | Conversion · Series A Preferred Stock | −260,380 | 0 | ||
| 2020-10-20 | Vivo Capital VIII, LLC 10% owner | Conversion · Series B-1 Preferred Stock | −523,726 | 0 | ||
| 2020-10-20 | Vivo Capital VIII, LLC 10% owner | Conversion · Series B-1 Preferred Stock | −72,320 | 0 | ||
| 2020-10-20 | Vivo Capital VIII, LLC 10% owner | Conversion · Series B-2 Preferred Stock | −224,054 | 0 | ||
| 2020-10-20 | Vivo Capital VIII, LLC 10% owner | Conversion · Series B-2 Preferred Stock | −30,939 | 0 | ||
| 2020-10-20 | Versant Venture Capital VI, L.P. 10% owner | Conversion | +2,145,991 | 2,145,991 | ||
| 2020-10-20 | Versant Venture Capital VI, L.P. 10% owner | Conversion | +198,839 | 2,344,830 | ||
| 2020-10-20 | Versant Venture Capital VI, L.P. 10% owner | Conversion | +85,065 | 2,429,895 | ||
| 2020-10-20 | Versant Venture Capital VI, L.P. 10% owner | Conversion | +463,959 | 463,959 | ||
| 2020-10-20 | Versant Venture Capital VI, L.P. 10% owner | Conversion | +198,485 | 662,444 | ||
| 2020-10-20 | Versant Venture Capital VI, L.P. 10% owner | Purchase | +200,000 | $15.00 | $3.0M | 862,444 |
| 2020-10-20 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series A Preferred Stock | −2,145,991 | 0 | ||
| 2020-10-20 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series B-1 Preferred Stock | −198,839 | 0 | ||
| 2020-10-20 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series B-1 Preferred Stock | −463,959 | 0 |
Page 9 of 12 · 238 trades